- AAF: Contra Biden Admin., monopoly is not a problem in the US economy.
- Richard McKensie: Trump’s “beautiful bill” will raise federal spending in 2035 to at least 24 percent of GDP from 23.1 percent this year (and 20.6 percent in 2019, before COVID)
- Use and misuse of Ivermectin.
- Covid Redux: “The Centers for Disease Control and Prevention advisory committee decided to inoculate essential workers ahead of seniors, even though its own modeling suggested this would increase deaths by up to 7 percent.”
- More evidence that taxes on capital affect investment.
Category: Wednesday Links
Wednesday Links
- Among beneficiaries without subsidies, the percent who did not fill a prescription for a specialty drug within 90 days was 30 percent for anticancer drugs, 22 percent for hepatitis C treatments, and more than 50 percent for disease-modifying therapies for either immune system disorders or hypercholesterolemia.
- Why Social Security finances will steadily worsen indefinitely into the future.
- On current trends Africans will make up over 80% of the world’s poor by 2030.
- Some hospitals are still getting hundreds of millions in Covid funding from FEMA. (Statnews)
- The federal government’s new-car fuel economy standards (CAFE) have resulted in thousands of traffic deaths.
Wednesday Links
- Claim: it was the Obama administration that paused funding for high-risk (gain of function) studies in 2014. The ban was lifted by none other than Donald Trump in 2017.
- Yarvin’s strange argument on populism and Gain-of-Function research
- Firing squads are making a comeback.
- US patients pay almost three times more than the average price paid in OECD countries for brand drugs, but we pay a third less than other countries for generics.
- The case against Medicaid budget cuts. (unimaginative)